Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
65.35
+0.57 (0.88%)
Apr 25, 2025, 1:45 PM EDT - Market open
Verona Pharma Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$66.83
Upside
+2.26%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $74 → $93 | Buy | Maintains | $74 → $93 | +42.31% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $75 | Strong Buy | Maintains | $60 → $75 | +14.77% | Feb 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $44 → $72 | Strong Buy | Maintains | $44 → $72 | +10.18% | Feb 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 → $60 | Strong Buy | Reiterates | $42 → $60 | -8.19% | Jan 21, 2025 |
| Roth MKM | Roth MKM | Strong Buy Initiates $68 | Strong Buy | Initiates | $68 | +4.06% | Jan 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $64 → $74 | Buy | Maintains | $64 → $74 | +13.24% | Jan 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $44 → $57 | Strong Buy | Reiterates | $44 → $57 | -12.78% | Jan 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $64 | Buy | Maintains | $50 → $64 | -2.07% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $42 | Strong Buy | Maintains | $36 → $42 | -35.73% | Nov 5, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $37 → $44 | Strong Buy | Maintains | $37 → $44 | -32.67% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $38 → $44 | Strong Buy | Maintains | $38 → $44 | -32.67% | Oct 9, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $50 | Buy | Initiates | $50 | -23.49% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | -44.91% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | -44.91% | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | -44.91% | Sep 11, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $35 → $37 | Strong Buy | Maintains | $35 → $37 | -43.38% | Jul 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.